Netherlands· NL-2a51e1eb6998

Dopaminehydrochloride Hikma 40 mg/ml, concentraat voor oplossing voor infusie

A dopamine product containing dopamine hydrochloride, registered in Netherlands by Hikma Farmaceutica (Portugal), S.A.. The same ATC class is registered in 16 of our 19 countries.

ATC C01CA04

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about dopamine hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Dopamine is registered in 16 of 19 countries.

Countries holding a registration under ATC C01CA04 (dopamine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search dopamine products by name

Dopamine · ATC C01CA04

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: DOPAMINE HYDROCHLORIDE
Manufacturer: Hikma Farmaceutica (Portugal), S.A.
Country: Netherlands (NL)
ATC code: C01CA04
ATC class: Dopamine
Defined daily dose: 0.5 g, P
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
116931

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

103 interactions on record for dopamine.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check dopamine against other medicines How interaction checks work

Dopamine · interactions on record

103 records

9 severe
91 moderate
3 minor

Most severe, free to view

ProcarbazineL01XB01severe
OzanimodL04AA38severe
OzanimodL04AE02severe
CocaineN01BC01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dopamine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dopamine products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

Austria · Dopamin Hikma, Giludop
Bulgaria · Допамин Wzf
Czechia · Tensamin
Germany · Dopamin Fresenius
Spain · Dopamina Basi, Dopamina Grifols
France · Dopamine Renaudin, Dopamine Viatris
United Kingdom (Northern Ireland) · Dopamine Hikma Farmacêutica (Portugal), Dopamine Hydrochloride Mercury Pharmaceuticals
Greece · Dopamine Anfarm, Dopamine Hcl Demo
Ireland · Dopamine Bp Mercury Pharmaceuticals (Ireland), Dopamine Hydrochloride Pfizer Healthcare Ireland
Iceland · Neoatricon
Italy · Dopamina Cloridrato Galenica Senese, Dopamina Cloridrato Hikma
Liechtenstein · Neoatricon
Lithuania · Dopamine Pph
Luxembourg · Dopamin Fresenius
Norway · Dopamin Evolan, Neoatricon
Poland · Dopaminum Hydrochloricum Wzf
Portugal · Dopamina Basi, Dopamina Hikma
Romania · Clorhidrat De Dopamină Zentiva
Slovenia · Dopamin Fresenius
Slovakia · Tensamin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e6b41e50-30a1-4c06-a070-3638787472b0
GET /v1/drugs/e6b41e50-30a1-4c06-a070-3638787472b0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentraat voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h116931_smpc.pdf",
  "strength": null,
  "atc_label": "Dopamine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg116931",
  "excipients": [
    "NATRIUMCHLORIDE",
    "NATRIUMMETABISULFIET (E 223)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "DOPAMINE HYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h116931.pdf",
  "authorised_at": "2017/12/05",
  "procedure_number": "PT/H/1303/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "116931",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about dopamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console